Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Cancer Pathogenesis and Therapy
|
November 3, 2025
Radiotherapy combined with first-line anti-programmed cell death protein 1 (PD-1) immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer: A bicentric retrospective study
Yu Huang, Peng Ding, Ruiguang Zhang, et al.
BMC Medicine
|
September 13, 2021
Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study
Yongchang Zhang, Xiangyu Zhang, Ruiguang Zhang, et al.
Microbiology Spectrum
|
November 17, 2021
Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis
Hui Lu, Na L Gao, Fan Tong, et al.
Chinese Medical Journal
|
September 23, 2024
The role of radiotherapy in extensive-stage small cell lung cancer after durvalumab-based immunochemotherapy: A retrospective study
Lingjuan Chen, Yi Kong, Fan Tong, et al.
Targeted Oncology
|
June 23, 2023
Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer
Nan Zheng, Yimin Zhang, Yue Zeng, et al.
Journal of Hematology & Oncology
|
July 22, 2020
CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer
Jian Wang, Ruiguang Zhang, Zhenyu Lin, et al.
Clinical and Translational Medicine
|
January 27, 2022
BRD4-IRF1 axis regulates chemoradiotherapy-induced PD-L1 expression and immune evasion in non-small cell lung cancer
Jian Wang, Yingzhuo Xu, Xinrui Rao, et al.
JCO Precision Oncology
|
March 23, 2023
Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With <i>ROS1</i>-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study
Zhe Huang, Huan Yan, Liang Zeng, et al.
Iscience
|
October 1, 2024
Development of a prognostic nomogram for advanced non-small cell lung cancer using clinical characteristics
Haoyue Qin, Zhe Huang, Huan Yan, et al.
Iscience
|
August 20, 2025
Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLC
Lianxi Song, Liang Zeng, Qinqin Xu, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Cancer Pathogenesis and Therapy
|
November 3, 2025
Radiotherapy combined with first-line anti-programmed cell death protein 1 (PD-1) immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer: A bicentric retrospective study
Yu Huang, Peng Ding, Ruiguang Zhang, et al.
BMC Medicine
|
September 13, 2021
Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study
Yongchang Zhang, Xiangyu Zhang, Ruiguang Zhang, et al.
Microbiology Spectrum
|
November 17, 2021
Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis
Hui Lu, Na L Gao, Fan Tong, et al.
Chinese Medical Journal
|
September 23, 2024
The role of radiotherapy in extensive-stage small cell lung cancer after durvalumab-based immunochemotherapy: A retrospective study
Lingjuan Chen, Yi Kong, Fan Tong, et al.
Targeted Oncology
|
June 23, 2023
Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer
Nan Zheng, Yimin Zhang, Yue Zeng, et al.
Journal of Hematology & Oncology
|
July 22, 2020
CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer
Jian Wang, Ruiguang Zhang, Zhenyu Lin, et al.
Clinical and Translational Medicine
|
January 27, 2022
BRD4-IRF1 axis regulates chemoradiotherapy-induced PD-L1 expression and immune evasion in non-small cell lung cancer
Jian Wang, Yingzhuo Xu, Xinrui Rao, et al.
JCO Precision Oncology
|
March 23, 2023
Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With <i>ROS1</i>-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study
Zhe Huang, Huan Yan, Liang Zeng, et al.
Iscience
|
October 1, 2024
Development of a prognostic nomogram for advanced non-small cell lung cancer using clinical characteristics
Haoyue Qin, Zhe Huang, Huan Yan, et al.
Iscience
|
August 20, 2025
Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLC
Lianxi Song, Liang Zeng, Qinqin Xu, et al.
Page
of 7